RecruitingNot ApplicableNCT06475040
TMS for Anxiety and Trauma-related Disorders
Accelerated Intermittent Theta Burst Stimulation to a Novel DLPFC Target for Anxiety and Trauma-related Disorders: a Pilot Study
Sponsor
Shanghai Mental Health Center
Enrollment
15 participants
Start Date
Jun 19, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The present pilot study will apply accelerated intermittent theta burst stimulation (aiTBS) to a novel transcranial magnetic stimulation (TMS) target for anxiety derived via causal network mapping.
Eligibility
Min Age: 18 YearsMax Age: 60 Years
Inclusion Criteria8
- Diagnosis of generalized anxiety disorder (GAD), social anxiety disorder (SAD), panic disorder (PD), and/or post-traumatic stress disorder (PTSD) as defined by DSM-5 criteria.
- Male or female between 18 and 60 years old.
- Right-handed.
- Can understand and sign an informed consent document.
- Beck Anxiety Inventory (BAI) score of 16 or higher.
- On a stable medication/psychotherapy regimen for at least 6 weeks prior to baseline visit and throughout the duration of the study.
- In good general health, as ascertained by medical history.
- Pharmacological treatment resistance or psychotherapeutic treatment resistance.
Exclusion Criteria8
- Substance use disorders, eating disorders, significant suicidal ideation, mental disorder due to a medical or neurocognitive condition, lifetime psychosis, bipolar disorder, developmental disorders.
- History of brain surgery and epilepsy.
- Presence of metallic foreign bodies, such as cardiac pacemakers and stents.
- Any medical condition or medication that increases the risk of seizures.
- Pregnancy.
- Intellectual disability.
- Current severe somatic disease, such as cancer, heart failure, pneumonia, etc.
- Severe claustrophobia that prevents the use of MRI.
Interventions
DEVICEtranscranial magnetic stimulation
non-invasive form of brain stimulation accelerated intermittent theta burst stimulation (aiTBS)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06475040
Related Trials
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
NCT000180571 location
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
NCT003971111 location
Modulating Anxious Coping
NCT048241051 location
Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
NCT071234671 location
Neurostimulation Versus Therapy for Problems With Emotions
NCT057120571 location